Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs

Go back to Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
(NASDAQ: ASMB) Delayed: 25.91 +0.36 (1.41%)
Previous Close $25.55    52 Week High $14.50 
Open $25.80    52 Week Low $4.33 
Day High $26.57    P/E N/A 
Day Low $25.80    EPS $0.00 
Volume 79,180